These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12160198)

  • 1. Skeletal muscle magnesium content is correlated with plasma glucose concentration in patients with essential hypertension treated with lisinopril or bendrofluazide.
    Haenni A; Reneland R; Andersson PE; Lind L; Lithell H
    Am J Hypertens; 2002 Aug; 15(8):735-8. PubMed ID: 12160198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups.
    Haenni A; Andersson PE; Lind L; Berne C; Lithell H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):615-22. PubMed ID: 7946163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle.
    Haenni A; Lind L; Lithell H
    Am J Hypertens; 1996 Mar; 9(3):273-6. PubMed ID: 8695028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
    Malminiemi K
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):295-304. PubMed ID: 7662596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.
    Djurhuus MS; Vaag A; Altura BM; Altura BT; Klitgaard NA
    Diabetes Metab; 2002 Jun; 28(3):201-7. PubMed ID: 12149600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance.
    Rattarasarn C; Leelawattana R; Soonthornpun S
    Metabolism; 2010 Feb; 59(2):172-6. PubMed ID: 19765781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension.
    Falkner B; Canessa M; Anzalone D
    Am J Hypertens; 1995 May; 8(5 Pt 1):454-60. PubMed ID: 7662220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
    Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
    Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
    Haenni A; Berglund L; Reneland R; Anderssson PE; Lind L; Lithell H
    Am J Hypertens; 1997 Feb; 10(2):145-51. PubMed ID: 9037321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role for insulin receptors in the mechanism of thiazide induced glucose tolerance.
    Gill JS; Al-Hussary N; Atkins TW; Taylor KG; Beevers DG
    J Hypertens Suppl; 1984 Dec; 2(3):S573-6. PubMed ID: 6599719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
    Engeli S; May M; Nussberger J; Danser AHJ; Dole WP; Prescott MF; Dahlke M; Stitah S; Pal P; Boschmann M; Jordan J
    J Am Soc Hypertens; 2017 Aug; 11(8):488-497. PubMed ID: 28666704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lisinopril in the monotherapy of patients with essential hypertension: the effect of therapy on glucose and lipid metabolism].
    Gajdos M; Spustová V; Dzúrik R
    Cas Lek Cesk; 1993 Dec; 132(23):709-14. PubMed ID: 8293440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
    Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
    Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
    Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
    Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus.
    Bonora E; Targher G; Alberiche M; Bonadonna RC; Saggiani F; Zenere MB; Uleri S; Muggeo M
    J Clin Endocrinol Metab; 1999 May; 84(5):1544-50. PubMed ID: 10323377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of muscle insulin sensitivity in obese men.
    Wilson M; Ross R
    Diabetes Metab; 2014 Apr; 40(2):161-4. PubMed ID: 24656962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors.
    De Cesaris R; Ranieri G; Filitti V; Andriani A; Lamontanara G
    Cardiology; 1993; 83(3):165-72. PubMed ID: 8281530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.